Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 26, 2001
Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line RehN R Wall, R M Mohammad, A M Al-KatibLeukemia Research|November 26, 1999
Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, RehN R Wall, R M Mohammad, A M Al-KatibThe Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 1, 1989
Detection of intracytoplasmic immunoglobulin by flow cytometry in B-cell malignanciesR H Bardales, A M Al-Katib, A Carrato, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 1, 1995
Induced expression of a ubiquitin COOH-terminal hydrolase in acute lymphoblastic leukemiaA M al-Katib, R M Mohammad, A Maki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: case reportI Ahmad, A M Al-Katib, F W Beck, et al.Enzyme & Protein|January 1, 1996
Bryostatin 1 induces ubiquitin COOH-terminal hydrolase in acute lymphoblastic leukemia cellsR M Mohammad, A Maki, G R Pettit, et al.Radiology|October 1, 1990
Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlationsW G Negendank, A M al-Katib, C Karanes, et al.International Journal of Molecular Medicine|January 20, 2000
Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, RehN R Wall, R M Mohammad, K B Reddy, et al.Journal of Drug Targeting|January 5, 2002
Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell lineN R Wall, F W Beck, A M Al-Katib, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft modelR M Mohammad, N R Wall, J A Dutcher, et al.Pageof 3